Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0410 per EA under NDC 65862020005. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
400 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862020005
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA078787On Market Since
1/31/2008
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 52.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0410 per EA |
|---|---|
| All-time high | $0.1011 (Feb 12, 2014) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0654 |
| Average price | $0.0648 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 16 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0410 per EA (NDC 65862020005), effective Jun 24, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 52.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Nov 28, 2013, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.1011 (Feb 12, 2014), with a median of $0.0654 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
16 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 400 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 65862020005) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification